Google TrendCHAMPIONS LEAGUE SCHEDULE (500+) — Champions League Matchday 2: Key stats and what to look out for in every game
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Development of allosteric" (30 stories)

Top Headline Story

Phage-assisted evolution of allosteric protein switches
Lead StoryNaturegeneral
Apr 14

Phage-assisted evolution of allosteric protein switches

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBXVm5zOWlDa0Y0dHU5WTdkcWdsS053eWpuTjJ1bXNGWXRhNFNNWXdZRDZSRHlyRE9xUUxnQUkyRHY1dHQ3U0FHR3lsLWVfZE0yeWhXam5vMnFtcGk1YkZZ?oc=5" target="_blank">Phage-assisted evolution of allosteric protein switches</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
500+17m ago

champions league schedule

Champions League Matchday 2: Key stats and what to look out for in every game

500+27m ago

matthew stone sr

Adult victims, suspected shooter ID'd in Erie mass shooting

500+27m ago

geomagnetic storm aurora visibility northern us

Northern Lights Forecast: Aurora Could Be Visible From These 10 States Monday

5000+47m ago

selma blair

Selma Blair Arrested, Attacks Flight Crew After Trying to Open Plane Door Mid-Air

Search Results for "Development of allosteric"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Deciphering the Structural Basis of Allosteric Inhibition of Mutant Epidermal Growth Factor Receptor and Identification of Novel Inhibitors
Science Partner Journalsgeneral

Deciphering the Structural Basis of Allosteric Inhibition of Mutant Epidermal Growth Factor Receptor and Identification of Novel Inhibitors

<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTFA4eGpCV09qbnlrdzhTT1M2S2xpWXp2WlplZ1kwbmp4cnJlcXpGTHowZzF0bkEwMHRJSlJET2tiVGhIdmxNZVl6dnZTMXFxclZpejFLNk9EV1Utdw?oc=5" target="_blank">Deciphering the Structural Basis of Allosteric Inhibition of Mutant Epidermal Growth Factor Receptor and Identification of Novel Inhibitors</a>  <font color="#6f6f6f">Science Partner Journals</font>

Roche pens backloaded $2B deal with Atavistik to discover allosteric CVRM drugs
Fierce Biotechgeneral

Roche pens backloaded $2B deal with Atavistik to discover allosteric CVRM drugs

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQckJsX2ZERERQYWpwWUw4Y2ZoWEFYVzVrbUtETDVNd2J6WHA3SVFRaWFoZXZVZGJLOHBySHJxdnM4azhPZFdQX3JSV3Nqck5sVlRNZGNoVi0zV1VYZVJoU1ZreWF4TUFMdEp0QWNHei1YdnBOM1ctMUI5SHFiUW5sMXlUdmExQ2Y1a3pWMVJiVG9hb09hZWk3NUlnLW00dmVXc3FZ?oc=5" target="_blank">Roche pens backloaded $2B deal with Atavistik to discover allosteric CVRM drugs</a>  <font color="#6f6f6f">Fierce Biotech</font>

Atavistik Bio Announces Strategic Research Collaboration
GlobeNewswireworld

Atavistik Bio Announces Strategic Research Collaboration

<a href="https://news.google.com/rss/articles/CBMingJBVV95cUxOaG1rS3Z5R3AwWGpyZWowY3B0VVd2cnJ3Y1Vocnl6SWtrUzJ0eGRvTEZqcVlCdzNpRFFMdUhTX29xQ3IwbkJ3LVdDaDU5ZVZ0VTB0WTlEcXY0U3J4NVgzU3RTWWJOSUlWbUZvY2UtZ0Nqd3VNTVRnNHYwQVZ3NWhYZzN6azZmQXBWNXVxMlQ2ekw4WjU1MWMzQWZrbW9kYTBFZUcyWlJfSUpZb2F4ZVhjRTBESjFSWF8wSVNLc2V4bnI2LVRVU1Vud3F4UlNSMVpJUW54UWx4Vks5Sy1TWTU4dE5BRXpDeTZVajgyQktFVE03M3g2M0JVWGVmcG1MVW4tb2d2bkdfT09zTG1uQWNKdzZsWERnMXg5ZTdGRzZR?oc=5" target="_blank">Atavistik Bio Announces Strategic Research Collaboration</a>  <font color="#6f6f6f">GlobeNewswire</font>

Next-generation allosteric modulators: A glance at the biotech pipeline in 2026
Labiotech.eutech

Next-generation allosteric modulators: A glance at the biotech pipeline in 2026

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE45cmpaRDZ1NlJORFltdDJkRV9yUFdBa21ILWhzeW5TSGEyY1dwQUd3dmpJbHhhajVQRlJZaEZVOGlQbENCTXBaeTJKdUZnbjF1QUJDbkpDLWtyZGVTeG1qQV9KZDRLM00?oc=5" target="_blank">Next-generation allosteric modulators: A glance at the biotech pipeline in 2026</a>  <font color="#6f6f6f">Labiotech.eu</font>

AOI Biosciences, Toshiba Secure Patent for Allosteric Drug Discovery Technology
International Business Timestech

AOI Biosciences, Toshiba Secure Patent for Allosteric Drug Discovery Technology

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOVW1hcHlsYVhpbFQzeTZzQ0NoR29yeWJ3Qzl6dFRJM3lXclFaSGhYUXhoUEdCa2NSU0FCakVGSlVQMlJSQ2YyTnhVMnhnUV93TDJWbnJvUVVZSDd0aHNnclBka3RvM3FPU256R3A2S3Q5bm1MVDJUOW9uZGR2bmtwUUpHUFozUGZsc0dHNjlkeVdiVmhPcHJOWF9DbjhEWXhBSzIxUmt0WQ?oc=5" target="_blank">AOI Biosciences, Toshiba Secure Patent for Allosteric Drug Discovery Technology</a>  <font color="#6f6f6f">International Business Times</font>

An evolution-conserved allosteric network in human tubulin governs paclitaxel efficacy
Naturegeneral

An evolution-conserved allosteric network in human tubulin governs paclitaxel efficacy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBZLTIwOGFZVGdtaWN5RDk1S3pFdWtPSERGckxJd2YtbThXN2xZVXNlLUd2VTNwQkktcUFadmZ4RFZwZzZvaXZ1aVNSMGQwWnQxRk1QUVpmb1g5Tmpmd0ow?oc=5" target="_blank">An evolution-conserved allosteric network in human tubulin governs paclitaxel efficacy</a>  <font color="#6f6f6f">Nature</font>

Development of Allosteric Ribozymes for ATP and l-Histidine Based on the R3C Ligase Ribozyme
Astrobiology Webgeneral

Development of Allosteric Ribozymes for ATP and l-Histidine Based on the R3C Ligase Ribozyme

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPaUtjSXBwVjUzckdWbExnS01yRjFBb1M4UWVoYzlrdlY4bHhUbEFCM0pPa0RqVF9UVXFvTDhCMEVlZDJQZ3NxVnVtRExYTkdUaW55NWVWNXdLXzQwblhjMG8tNVRCUUVmOE1lUjVXaGxZM1p1dHVDTXdFZF8xby1jeFdkUUFVMWZkMEFtdEhJdm1FREFmNFVBTTkxNENET0lNelV3Slp3OFNTUjJKdV9EVk1hdHNPdzIxZzMyWE5XV1ZGUlVMVFgtQw?oc=5" target="_blank">Development of Allosteric Ribozymes for ATP and l-Histidine Based on the R3C Ligase Ribozyme</a>  <font color="#6f6f6f">Astrobiology Web</font>

Why allosteric drugs represent a unique small molecule approach
www.drugdiscoverytrends.comworld

Why allosteric drugs represent a unique small molecule approach

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQbkZHYVQxbUZNd0ZyQXozb2lUNFd5aHVqb2lYajJhUzVMWVpURmViVzBwWW1PRndHUkl3X2xORzBfek5DR2FEeEVSLUpCSm1FZ0hMZVlCQ21xdXlhNEV5QVl4SS1QZ2J6cEIyMjRXQ0ZqMTFEYWJQVzg4S2dqRklHN2dvdVFnSkJLUHNuSlpRWkN2QXVXcFAzVzV3?oc=5" target="_blank">Why allosteric drugs represent a unique small molecule approach</a>  <font color="#6f6f6f">www.drugdiscoverytrends.com</font>

Recent applications of computational methods to allosteric drug discovery
Frontiersgeneral

Recent applications of computational methods to allosteric drug discovery

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQT1hmazgxcnpFVFpGd2N6c0FYTG8zY1NLMFp5aVBDMmhxZWdiLVZHV3hQSHJnejA0a3VvY2RRXzV3SjliOHl5dEx5Q2JKcWx6aHNZaVVDOFVtOV9xUzFhRFFOTFBvOXk3bnNLR3dSWTc3ZVhHRkFheHdscGhMMjRXODBBZm5lTjNhek5wRnl1MUFKTTNBNmNlWllNd0dSTVdx?oc=5" target="_blank">Recent applications of computational methods to allosteric drug discovery</a>  <font color="#6f6f6f">Frontiers</font>

Drug hunters explore allostery’s advantages
Chemical & Engineering Newsworld

Drug hunters explore allostery’s advantages

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQRl9Fc1I1TEluRDFDbFQyd2Fnai02M2pSRzdWdFpVdjk5N2c5OGJiWXRrd3UwMGJHMmoweGQzelhmWUZwQWptUFlSaE5DNHI3OHp0aTAxa1BoZFhXMFNJaTdEOVg0RmVzVWRpY3k1OE5BSFVyYjJQd0RWb3I2OUhaNEFrM1dVMElZZzkzWUpFcVhDYmh6eldXdDBFQ3o0TDNCRk41Mg?oc=5" target="_blank">Drug hunters explore allostery’s advantages</a>  <font color="#6f6f6f">Chemical & Engineering News</font>

Pfizer & Atavistik Bio Partner to Discover Allosteric Therapeutics
The Clinical Trial Vanguardgeneral

Pfizer & Atavistik Bio Partner to Discover Allosteric Therapeutics

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQeUE2RHpqUlBJUlF5dTB6dlU3M25veThWMmJFaXVUUUhEcTJTeDJMNzZyY3QzdDBNeDVyaGZVRW0xZHJZZzNCM2Q3T19BTjdnWF9XMkJZeHhnS0E2Ujl5NkFMclZWeDBST3dPTTNhTlJrUXhZbnRCUFNKTFFfMmNBSUFFOGVTblpmcVQ0Sm0zRGNNOHlZWlpkb09FS2VqbExfeUJaTVJlTUJwRDRa?oc=5" target="_blank">Pfizer & Atavistik Bio Partner to Discover Allosteric Therapeutics</a>  <font color="#6f6f6f">The Clinical Trial Vanguard</font>

New Promise and Opportunities for Allosteric Kinase Inhibitors - Lu - 2020 - Angewandte Chemie International Edition
Wiley Online Libraryworld

New Promise and Opportunities for Allosteric Kinase Inhibitors - Lu - 2020 - Angewandte Chemie International Edition

<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE9uMDY1dWwzbUlycmFXV1VLZk1Ld0RSRmlhR0NKbjRKYy1nX1REb0lLNy1JbUc0cW9nY3lpemVHTkpiaFd1OTVHWXVPTzZBdjUyQ1c1Nzg3aU53cERjNVBYVmJPaFBIUHFDeFFvTnk5SQ?oc=5" target="_blank">New Promise and Opportunities for Allosteric Kinase Inhibitors - Lu - 2020 - Angewandte Chemie International Edition</a>  <font color="#6f6f6f">Wiley Online Library</font>

Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding
Naturegeneral

Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA5NVZ4X0VhakFkdl8xalMzRUZEOUpZNl9PMGs1eVhuQVZjQWppdzRiYjNSdVU3Zi1sTGtIc3FlR2hrRDlSc09RWm92REY5NExLUmxDR3hUdHY0Tk9wOHZ3?oc=5" target="_blank">Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding</a>  <font color="#6f6f6f">Nature</font>

Atavistik Bio Raises $120 Million Series B Financing to
GlobeNewswiretech

Atavistik Bio Raises $120 Million Series B Financing to

<a href="https://news.google.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?oc=5" target="_blank">Atavistik Bio Raises $120 Million Series B Financing to</a>  <font color="#6f6f6f">GlobeNewswire</font>

Development of an allosteric adhesion GPCR nanobody with therapeutic potential
Naturegeneral

Development of an allosteric adhesion GPCR nanobody with therapeutic potential

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9ZQkpEVzJiSmROM0lLSkZpR0F2cl9VVGMzazVLMjV1T3RsYU1LUFJtRkJhVUw3MnZtSmQwUmJ4SGxpMW13SjFJRWY3MFhXRS1WMDJZaHNyLTJZbHdZRmZN?oc=5" target="_blank">Development of an allosteric adhesion GPCR nanobody with therapeutic potential</a>  <font color="#6f6f6f">Nature</font>

Design and optimization of a kinase-controlled allosteric switch
Naturegeneral

Design and optimization of a kinase-controlled allosteric switch

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBkNnBEekFyWDRiZkhMQjVDNlVOekYzWTEyQ1NSajFxaE5hbUVCQUZXU1JPNy1Ic0lYdGFzdmxCR3JXZzZBb3NHRkwtMEthb1ktWkpPdDFULXgtUWJVclhZ?oc=5" target="_blank">Design and optimization of a kinase-controlled allosteric switch</a>  <font color="#6f6f6f">Nature</font>

Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors
Naturegeneral

Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9hRGhsTWJodzRERk8yblhRcVFlRHJWOFN3bUVwV2R1b0I1Yl9Ta3BiMHRYUjV3NXNMX2hsNlN5bkduZUxaMUhJWjV4RXNaVk5CSVc2c1N2MkQ0YjhGQWRj?oc=5" target="_blank">Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors</a>  <font color="#6f6f6f">Nature</font>

Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development
Naturegeneral

Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9BT1BRNXhEbnEzRXBRRGxUd0wzX0UyNGxNWmR6akRTNVdMOS10VDM0b0pxOVV3blpsaGFFV09RbHFORUsxOHpyNmdqMVBsa1NkSE1pOFQ3SEdjRXZfVV9z?oc=5" target="_blank">Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development</a>  <font color="#6f6f6f">Nature</font>

Pain management beyond opioids: a β-arrestin2-biased allosteric GPCR modulator opens new avenues for drug development | Signal Transduction and Targeted Therapy
Naturetech

Pain management beyond opioids: a β-arrestin2-biased allosteric GPCR modulator opens new avenues for drug development | Signal Transduction and Targeted Therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBQRGxsR1RsNE9ZYVJkU2RMMlJ6VjZNeEtvNXNGVkpwc1dyTXg0WlBPZ25FelJOWG5fdGtOVVl4aF94S0F5T1VUQWJlZzViRXFNcTFXdHBwUm8xZkxTSExR?oc=5" target="_blank">Pain management beyond opioids: a β-arrestin2-biased allosteric GPCR modulator opens new avenues for drug development | Signal Transduction and Targeted Therapy</a>  <font color="#6f6f6f">Nature</font>

Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery
Wiley Online Librarygeneral

Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBLTXNNSThkTXJUNGVVUEFfSG1NZmtrWkdkM2VEYUQxaUNtU2FfdktrT2ZNekh0MWtNUk0tbVNkR1hudkVwT0tuMGo1dXVtZFBoYjQzWjZoa2ZiNGc2cHZvdHVKa2dkY2o4MkE?oc=5" target="_blank">Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery</a>  <font color="#6f6f6f">Wiley Online Library</font>

THEMIS is a substrate and allosteric activator of SHP1, playing dual roles during T cell development
Naturegeneral

THEMIS is a substrate and allosteric activator of SHP1, playing dual roles during T cell development

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1IaHQ4SzZmeU90Zi13a3d6c1BZWWFSME53dnZoNkl1WkhNWWJDaFNGM1NIRlpnTGJuY3hzRmgzWlVOZFZrMGprR0x4Q2pVX2Rua0RpOWpubHJ0OFhIbGF3?oc=5" target="_blank">THEMIS is a substrate and allosteric activator of SHP1, playing dual roles during T cell development</a>  <font color="#6f6f6f">Nature</font>

Cheminformatics-aided discovery of potential allosteric site modulators of ubiquitin-specific protease 7
Naturetech

Cheminformatics-aided discovery of potential allosteric site modulators of ubiquitin-specific protease 7

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5WYXAzRDdvYjBkZk1RcW1lNzhkdGhBN1NTaXE2LWpaaGJ3cmxfQ0Y0MVgxTzlkVkVKRmRWQTBkQWRnbnZURDJ6RmphWmV4YVJVV0JrOW8tdk1WMFdXYUNZ?oc=5" target="_blank">Cheminformatics-aided discovery of potential allosteric site modulators of ubiquitin-specific protease 7</a>  <font color="#6f6f6f">Nature</font>

Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Ta | DDDT
Dove Medical Presstech

Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Ta | DDDT

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxPMDUzTmRIX2dHQUJGVUxKQldpNUhsa2wtSGVDUXU2aHpLcElEbzMwRE5xQ3JuMVBPNFAyNW5WdGtMck9Pc3FJUHY0OGhfZnZtZ3NKTE1EWXpKaUhZSVFsRzRPdUNHbm1jOVhGM3QxZlI0NzJKWFhyck9UemdTTXNmQnZaeC1yVnFaLTFEUXg1VEkzOFNBYmxDR241YjFLTlh6V1RaWDJiSVBrMXJseVZUTjQ4TGNpalg4bS1RUTVMSzBBVERFVVFVQVVQS3E?oc=5" target="_blank">Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Ta | DDDT</a>  <font color="#6f6f6f">Dove Medical Press</font>

PASSerRank: Prediction of allosteric sites with learning to rank - Tian - 2023 - Journal of Computational Chemistry
Wiley Online Librarygeneral

PASSerRank: Prediction of allosteric sites with learning to rank - Tian - 2023 - Journal of Computational Chemistry

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5oLW1oNGpoSXFTLVM3TTc4T0s3WHREVEI4UFVtN2dyMUROTGM5Rk9jMzFhSVJacTczT1RvQ3h2bmxUelVORmNHY1UwMFR0aVpLWi1GRlJJVENOUFNoakYzb3Byc0gwa0tYM3c?oc=5" target="_blank">PASSerRank: Prediction of allosteric sites with learning to rank - Tian - 2023 - Journal of Computational Chemistry</a>  <font color="#6f6f6f">Wiley Online Library</font>

Allosteric activation of cell wall synthesis during bacterial growth
Naturegeneral

Allosteric activation of cell wall synthesis during bacterial growth

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE8tZHZSLUl4QXF0dl9QZndCdkE1ZjdjajMyLVZVbDJmS0tBMS1BSEhreVRKX01QTmh0a2lwcHNpM1FROC10dDVhdWRpc0pGRWNNdXJhcDFxUEtqU2FOMzZR?oc=5" target="_blank">Allosteric activation of cell wall synthesis during bacterial growth</a>  <font color="#6f6f6f">Nature</font>

PASSer2.0: Accurate Prediction of Protein Allosteric Sites Through Automated Machine Learning
Frontiersgeneral

PASSer2.0: Accurate Prediction of Protein Allosteric Sites Through Automated Machine Learning

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQMVNNbnZLb1AxeGNkbEE2RHR3QlFDWm5yYm9SemFuelZRZnRNMmU0MG5XSndKTEpGd2FHc19uYWRNNGd1NFhfTC1jYzl6bHFfTk5MLTBUX2pmVTlIVk5Hak1HbWQ5amgwM3E3eEk4YVRsRUxjZ3EzMF96WU9aZy1EaFBKcXVIVWRSemoyVmFfWGNtaDhmSmZQZ2ZZUlJaVjA?oc=5" target="_blank">PASSer2.0: Accurate Prediction of Protein Allosteric Sites Through Automated Machine Learning</a>  <font color="#6f6f6f">Frontiers</font>

Developing nanobodies as allosteric molecular chaperones of glucocerebrosidase function
Natureworld

Developing nanobodies as allosteric molecular chaperones of glucocerebrosidase function

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1pMHEwU3pJWXJPOTh3eGpPaDVJcGxBSWlMMXppYmhVQzVzREg1QzhaTlBJOUhDX2R0MDZPMmVrcVBta2RsbTZqUXg0akplWGprZUdwTW5LV3hUWVdfU3Yw?oc=5" target="_blank">Developing nanobodies as allosteric molecular chaperones of glucocerebrosidase function</a>  <font color="#6f6f6f">Nature</font>

Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises
ACS Publicationsgeneral

Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNUnJhUnc4UU9Qc3ZNNnVPdzlGU3R6Q0ltLVlKSmZjMDNKWFpxeFNUelBELWhyakxWMENEVEVrTGJ0S3loRWZUY3o5VUplM2ZKTXY5Rk1NNjZsUXdUS0REcmpFYWxMNkpwZGY3TkZyZmF4NDNhTWlsQlNMUTFOS0FucTRIX3RvdDRBWFJVeUtzeGVDV0ZiTkkxdkYzRS03QQ?oc=5" target="_blank">Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises</a>  <font color="#6f6f6f">ACS Publications</font>

Recent advances in the development of GRK2 inhibitors: blocking the interaction of GRK2 with its partners
Naturegeneral

Recent advances in the development of GRK2 inhibitors: blocking the interaction of GRK2 with its partners

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5ZTUFQeDJfbmY3cDZtX0pBWEMzMjN6bHhOcVVmQkxWX1hjMDV3akVYNHdEMlloYkhYOEVhcTU4bVBjVW82ZkZIZExTcndMOEJlakFPZ0lvc0U5T3J3V0NZ?oc=5" target="_blank">Recent advances in the development of GRK2 inhibitors: blocking the interaction of GRK2 with its partners</a>  <font color="#6f6f6f">Nature</font>

"Development of allosteric" — Live Google News Trends & Headlines